Log in to save to my catalogue

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03602123v1

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

About this item

Full title

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Publisher

Springer Verlag

Journal title

Drug safety, 2020-07, Vol.43 (7), p.615-617

Language

English

Formats

Publication information

Publisher

Springer Verlag

More information

Scope and Contents

Contents

L'infection pandémique par le coronavirus 2019 (COVID-19) qui se propage depuis la Chine génère un énorme flux d'informations et un point émergent est l'association fréquente de l'infection par le COVID-19 avec des anomalies hépatiques. Des études chinoises ont montré une augmentation des transaminases et d'autres enzymes hépatiques chez 14 à 53 %...

Alternative Titles

Full title

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03602123v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03602123v1

Other Identifiers

ISSN

0114-5916

DOI

10.1007/s40264-020-00954-z

How to access this item